News for Marinus Pharmaceuticals Stock (MRNS)

Marinus Pharmaceuticals Announces Ganaxolone Approved in China as First Treatment for Seizures Associated with CDKL5 Deficiency Disorder

Business Wire • 07/18/24

The Schall Law Firm Starts An Investigation Into Marinus Pharmaceuticals Inc And Encourages Affected Investors To Begin Dialogue

Accesswire • 07/17/24

Marinus Pharmaceuticals, Inc. Class Action: Levi & Korsinsky Reminds Marinus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2024 – MRNS

Accesswire • 07/17/24

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNS

GlobeNewsWire • 07/17/24

Marinus Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before August 5, 2024 to Discuss Your Rights - MRNS

PRNewsWire • 07/17/24

Levi & Korsinsky Notifies Shareholders of Marinus Pharmaceuticals, Inc.(MRNS) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire • 07/16/24

The Schall Law Firm Commences A Probe Into Marinus Pharmaceuticals Inc And Urges Impacted Investors To Initiate Discussion

Accesswire • 07/16/24

Levi & Korsinsky Notifies Marinus Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – MRNS

GlobeNewsWire • 07/16/24

Marinus Pharmaceuticals, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – MRNS

Accesswire • 07/15/24

The Gross Law Firm Reminds Marinus Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2024 – MRNS

GlobeNewsWire • 07/15/24

MRNS SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit!

Accesswire • 07/14/24

The Schall Law Firm Initiates An Inquiry Into Marinus Pharmaceuticals Inc And Urges Impacted Investors To Start Conversation

Accesswire • 07/13/24

ROSEN, A LEADING AND RANKED FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNS

GlobeNewsWire • 07/13/24

MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Fraud Lawsuit

PRNewsWire • 07/11/24

The Schall Law Firm Begins A Probe Into Marinus Pharmaceuticals Inc And Urges Impacted Investors To Initiate Communication

Accesswire • 07/11/24

Levi & Korsinsky Reminds Marinus Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2024 - MRNS

Accesswire • 07/11/24

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNS

GlobeNewsWire • 07/10/24

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 5, 2024 in Marinus Lawsuit – MRNS

Accesswire • 07/10/24

Levi & Korsinsky Notifies Shareholders of Marinus Pharmaceuticals, Inc. (MRNS) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire • 07/10/24

Marinus Pharmaceuticals, Inc. Class Action: The Gross Law Firm Reminds Marinus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 5, 2024 – MRNS

GlobeNewsWire • 07/09/24

The Schall Law Firm Starts An Investigation Into Marinus Pharmaceuticals Inc And Calls On Affected Investors To Make Contact

Accesswire • 07/09/24

The Schall Law Firm Begins A Probe Into Marinus Pharmaceuticals Inc And Encourages Impacted Investors To Get In Touch

Accesswire • 07/08/24

Investors who Lost Money on Marinus Pharmaceuticals, Inc.(MRNS) Should Contact Levi & Korsinsky About Pending Class Action - MRNS

Accesswire • 07/08/24

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNS

GlobeNewsWire • 07/08/24

An Inquiry Into Marinus Pharmaceuticals Inc Is Launched By The Schall Law Firm, Encouraging Impacted Investors To Commence Dialogue

Accesswire • 07/07/24